97. Ulcerative colitis Clinical trials / Disease details

Clinical trials : 2,527 / Drugs : 1,465 - (DrugBank : 259) / Drug target genes : 144 - Drug target pathways : 202

3 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03565939 (ClinicalTrials.gov)	May 4, 2018	22/5/2018	Probiotic Treatment of Ulcerative Colitis With Trichuris Suis Ova (TSO)	Probiotic Treatment of Ulcerative Colitis With Trichuris Suis Ova (TSO)	Ulcerative Colitis Chronic Moderate	Biological: Trichuris suis ova;Biological: Placebo	ParaTech A/S	NULL	Active, not recruiting	18 Years	75 Years	All	119	Phase 2	Denmark
2	EUCTR2017-004772-65-DK (EUCTR)	05/02/2018	04/12/2017	Probiotic Treatment of Ulcerative Colitis with Trichuris suis ova (TSO)	Probiotic Treatment of Ulcerative Colitis with Trichuris suis ova (TSO) - PROCTO	Ulcerative Colitis MedDRA version: 20.1;Level: LLT;Classification code 10045365;Term: Ulcerative colitis;System Organ Class: 100000004856;Therapeutic area: Diseases [C] - Digestive System Diseases [C06]	Product Code: TSO INN or Proposed INN: TSO Other descriptive name: SUSPENSION CONTAINING 7500 EMBRYONATED VIABLE TRICHURIS SUIS OVA/15ML	ParaTech A/S	NULL	Not Recruiting			Female: yes Male: yes	120	Phase 2	Denmark
3	NCT01953354 (ClinicalTrials.gov)	November 2013	24/9/2013	Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis	A Prospective, Randomized, Double-blind, Placebo-controlled Phase II Clinical Study of Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis and Its Effects on Mucosal Immune State and Microbiota	Colitis, Ulcerative	Biological: Trichuris suis ova (TSO);Biological: Placebo	National Institute of Allergy and Infectious Diseases (NIAID)	Coronado Biosciences, Inc.;Autoimmunity Centers of Excellence	Terminated	18 Years	70 Years	All	16	Phase 2	United States